Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
VEGFA overexpression
i
Other names:
VEGFA, Vascular endothelial growth factor A, VEGF, Vascular Endothelial Growth Factor A121, Vascular Endothelial Growth Factor A165, Vascular Endothelial Growth Factor, VEGF-A, MVCD1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7422
Related biomarkers:
Expression
Mutation
Others
‹
›
Associations
(7)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma (NCT00381797)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Completed
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
11/28/2017
Initiation :
08/01/2006
Primary completion :
10/01/2015
Completion :
10/01/2015
KDR • EPAS1 • CA9
|
VEGFA overexpression • VEGFA expression • CA9 expression
|
Avastin (bevacizumab) • irinotecan
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login